In the Caribbean island of Guadeloupe, patients with atypical parkinsonism develop a progressive supranuclear palsy-like syndrome, named Guadeloupean parkinsonism. Unlike the classical forms of progressive supranuclear palsy, they develop hallucinations and myoclonus. As lesions associated with Guadeloupean parkinsonism are poorly characterized, it is not known to what extent they differ from progressive supranuclear palsy. The aim of the present study was to determine the structural and metabolic profiles of Guadeloupean parkinsonism compared with progressive supranuclear palsy and controls using combined structural and diffusion magnetic resonance imaging and magnetic resonance spectroscopy. We included 9 patients with Guadeloupean parkinsonism, 10 with progressive supranuclear palsy and 9 age-matched controls. Magnetic resonance imaging examination was performed at 1.5 T and included 3D T 1 -weighted and fluid-attenuated inversion recovery images, diffusion tensor imaging and single voxel magnetic resonance spectroscopy in the lenticular nucleus. Images were analysed using voxel-based morphometry, voxel-based diffusion tensor imaging and brainstem region of interest measurements. In patients with Guadeloupean parkinsonism, structural and diffusion changes predominated in the temporal and occipital lobes, the limbic areas (medial temporal, orbitofrontal and cingulate cortices) and the cerebellum. In contrast to patients with progressive supranuclear palsy, structural changes predominated in the midbrain and the basal ganglia and diffusion abnormalities predominated in the frontocentral white matter, the basal ganglia and the brainstem. Compared with controls, the N-acetylaspartate to creatinine ratio was decreased in patients with progressive supranuclear palsy and to a lesser extent in patients with Guadeloupean parkinsonism. The pattern of structural and diffusion abnormalities differed between progressive supranuclear palsy and Guadeloupean parkinsonism. Widespread cortical atrophy was observed in patients with Guadeloupean parkinsonism who presented marked cognitive changes and hallucinations, whereas midbrain lesions were less severe than in progressive supranuclear palsy. Midbrain (progressive supranuclear palsy) or cortical (Guadeloupean parkinsonism) atrophy was a distinctive neuroimaging feature for differential diagnosis.
Introduction
In the French Caribbean island of Guadeloupe, patients with atypical parkinsonism represent two thirds of all cases of parkinsonism. In Guadeloupe, atypical parkinsonism is exceptionally frequent compared with the incidence in European countries, where it accounts for only $5% of all cases (Tolosa et al., 2006) . Epidemiological and experimental evidence suggests that it might have an environmental cause, most likely related to the consumption of annonacin, an inhibitor of complex I of the mitochondrial respiratory chain (Caparros-Lefebvre and Elbaz, 1999; Lannuzel et al., 2002 Lannuzel et al., , 2003 Lannuzel et al., , 2007 Champy et al., 2004 Champy et al., , 2005 EscobarKhondiker et al., 2007) . The clinical entity is a unique combination of levodopa-resistant parkinsonism, tremor, myoclonus, hallucinations, rapid eye movement sleep behaviour disorder and frontosubcortical dementia . In half of the patients, supranuclear gaze abnormalities suggest that the disease might be a form of progressive supranuclear palsy. However, compared with classical progressive supranuclear palsy, Guadeloupean parkinsonism has several unusual characteristics, including hallucinations, dysautonomia , rapid eye movement sleep behaviour disorder (De Cock et al., 2007) and cortical myoclonus (Apartis et al., 2008) . In a subgroup of patients who have been studied clinically and electrophysiologically, the oculomotor abnormalities differed from those observed in classical progressive supranuclear palsy. Vertical and horizontal saccade slowing related to brainstem lesions were minimal, whereas cortical dysfunctions at the origin of increased saccade latencies and high antisaccade error rates were significant (Apartis et al., 2008) .
Neuroimaging has helped determine the brain regions that are affected in Guadeloupean parkinsonism. Visual examination of structural MRI has reported widespread atrophy of the cerebral cortex, especially in the frontal and temporal lobes, enlargement of the third ventricle in all patients with Guadeloupean parkinsonism and mild mesencephalic atrophy observed in half of these patients . This contrasts with the classical form of progressive supranuclear palsy (Litvan et al., 1996) , in which marked to moderate mesencephalic atrophy with enlargement of the interpeduncular angle is a strong feature (Oba et al., 2005; Paviour et al., 2006) .
Recent MRI techniques, such as voxel-based morphometry (VBM) and diffusion imaging, have been used for the characterization and differentiation of parkinsonian syndromes, with a special interest in progressive supranuclear palsy (Blain et al., 2006; Nicoletti et al., 2006; Padovani et al., 2006; Nilsson et al., 2007; Paviour et al., 2007; Rizzo et al., 2008) . VBM detects voxel-wise changes in brain structure (Ashburner and Friston, 2000) .
Diffusion tensor imaging (DTI) is sensitive to the random motion of water molecules (Le Bihan et al., 2001) . DTI provides quantitative information on the magnitude (diffusivity) and orientation (anisotropy) of water diffusion in the brain and is therefore a promising tool for the study of white matter pathologies. Although progressive supranuclear palsy and Guadeloupean parkinsonism share similar symptoms, subtle differences in clinical and neurophysiological characteristics suggest that the pattern of morphological lesions may be different between the two. The aim of the study was to better characterize the lesion pattern in Guadeloupean parkinsonism as compared to classical progressive supranuclear palsy using multimodal MRI [i.e. VBM, voxel-based DTI, individual region-of-interest measurements, magnetic resonance spectroscopy (MRS)]. Given the clinical profile in patients with Guadeloupean parkinsonism, especially with regard to cognition, oculomotor disturbances and the presence of cortical myoclonus, we speculated on cortical rather than midbrain involvement in Guadeloupean parkinsonism as opposed to classical progressive supranuclear palsy.
Patients and methods

Subjects
The clinical characteristics of the patients and controls are summarized in Table 1 . We included 10 patients with progressive supranuclear palsy, 9 patients with Guadeloupean parkinsonism and 9 healthy age-matched volunteers with no history of neurological disorders. From the group of 51 patients with Guadeloupean parkinsonism recruited prospectively from the Neurology Department of the University Hospital of Pointe-à -Pitre between September 2003 and September 2005 , 9 patients asked for a second opinion in Paris, which allowed inclusion in the study. Patients underwent extensive clinical characterization (De Cock et al., 2007; Apartis et al., 2008) . Patients with Guadeloupean parkinsonism fulfilled the following inclusion criteria: levodopa-unresponsive parkinsonism, frontal dysfunction, early postural instability or falls and oculomotor dysfunction . Most of them had hallucinations and myoclonus (Table 1) . Patients with progressive supranuclear palsy were selected according to the National Institute of Neurological Disorders and Stroke diagnostic criteria (Litvan et al., 1996) and corresponded to the Richardson's syndrome subtype recently defined by Williams et al. (2005) . Patients with progressive supranuclear palsy were consecutively recruited from the Movement Disorders Clinic, Salpê triè re Hospital, Paris.
A complete neurological examination was performed and severity of extrapyramidal symptoms was quantified using the Unified Parkinson's Disease Rating Scale part III (Fahn et al., 1987) . All patients had electrooculographic recordings of horizontal eye movements, i.e. visually guided saccades (Apartis et al., 2008) . Cognitive impairment was assessed using the Mini-Mental State Examination (Folstein et al., 1975) and the Frontal Assessment Battery (Dubois et al., 2000) . Patients and controls gave written informed consent and the study was approved by the Local Ethics Committee.
Image acquisition
Images were acquired using a 1.5 T system and a standard head coil for signal reception (GE Medical Systems, Milwaukee, WI, USA). The protocol included high-resolution anatomical T 1 -weighted, DTI and axial fluid-attenuated inversion recovery images. Anatomical scans were acquired using an axial 3D inversion recovery fast spoiled gradient recalled acquisition (inversion time 600 ms, repetition time/echo time 10.3 ms/2 ms, 1 average, voxel size, 1 Â 1 Â 1.3 mm 3 ). DTI was performed using echo-planar imaging. DTI axial slices were obtained using the following parameters: repetition time/echo time/flip angle = 10 s/88 ms/90 , matrix 128 Â 128, field of view 380 Â 380 mm 2 , slice thickness 3 mm, no gap (3 mm isotropic voxels), four averages and acquisition time 5:20 min. A single voxel MRS was acquired in the lenticular nucleus at long echo time (point resolved spectroscopy sequence, repetition time 1500 ms, echo time 135 ms, voxel size 15 Â 30 Â 15 mm 3 ). The voxel was limited laterally by the external border of the lenticular nucleus, medially by the medial border of the globus pallidum and by the anterior and posterior borders of the putamen rostrally and caudally.
Diffusion image processing
Raw diffusion-weighted data were corrected for motion and geometric distortions secondary to eddy currents using a registration technique based upon the geometric model of distortions (Mangin et al., 2002) . Maps of fractional anisotropy and apparent diffusion coefficient, which corresponds to one third the trace of the diffusion tensor [Trace (D)/3], were calculated from the diffusion-weighted images using the FSL software (http://www.fmrib.ox.ac.uk/fsl/fdt/index.html).
Voxel-based morphometry analysis Procedure
Data processing and analysis were performed using statistical parametric mapping software (SPM5, Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK, http://www.fil.ion.ucl .ac.uk/spm/) and MATLAB version 7.0.1 (The Mathworks, Inc., MA, USA) Friston, 2000, 2005) . Native T 1 -weighted magnetic resonance volumes were segmented to obtain the grey matter, white matter and cerebrospinal fluid (CSF) images, and non-brain voxels were removed. The T 1 -weighted magnetic resonance volumes of all subjects were spatially normalized with non-linear registration to the T 1 Montreal Neurological Institute template, which approximates the space defined by Talairach and Tournoux (1988) . Segmented images were then normalized using the non-linear normalization parameters of the T 1 -weighted magnetic resonance volume and were resliced to a voxel size of 2 Â 2 Â 2 mm 3 . Jacobian modulation was performed on the segmented normalized grey and white matter images, which were then smoothed with an 8 mm filter full-width at half maximum isotropic Gaussian kernel. The resulting smoothed, normalized regions contained the average amount of grey or white matter within a region surrounding a voxel.
Voxel-based diffusion tensor imaging analysis Statistical parametric mapping data analysis
To allow voxel-by-voxel statistical comparisons, the echo-planar images (T 2 -weighted images obtained for b = 0) and the diffusion maps of all subjects were normalized to the standard Montreal Neurological Institute space using SPM5 software and resliced to a voxel size of 3 Â 3 Â 3 mm 3 . The diffusion maps were first coregistered to the T 1 -weighted images and then spatially normalized using the parameters determined from the normalization of the T 1 -weighted images obtained using linear steps with 12 degrees of freedom and 16 non-linear iterations. The normalized fractional anisotropy and apparent diffusion coefficient maps were smoothed with an 8 mm isotropic Gaussian kernel. This filter size corresponded to the spatial extent of the expected patient-control differences in the midbrain and allowed the anisotropy data to conform more closely to a Gaussian field model by reducing the proportion of voxels with non-normally distributed residuals (Jones et al., 2005) .
Radiological examination and individual region of interest measurements Visual assessment
The images were visually examined to look for several morphological and signal changes that were previously described in patients with progressive supranuclear palsy (Schrag et al., 2000; Righini et al., 2004; Graber and Staudinger, 2009) . Changes included the superior profile of the midbrain on the midsagittal T 1 -weighted images, midbrain atrophy on axial T 1 -weighted images and changes in signal intensity on T 2 -weighted fluid-attenuated inversion recovery images; the presence or absence of hypersignal in the midbrain and hyposignal in the posterolateral putamen greater or equal to that in the globus pallidus (Righini et al., 2004) was evaluated. The presence or absence of the hummingbird sign was also evaluated (Kato et al., 2003) . The superior profile of the midbrain was assessed as previously described using a 0-2 scale: 0 = normal convexity; 1 = abnormal flat; 2 = abnormal concave (Righini et al., 2004) . The superior profile of the midbrain was represented by an imaginary curve connecting a point immediately posterior to the mammillary body and the one located at the upper orifice of the aqueduct. The axial atrophy was assessed using a 0-3 scale (0 = normal; 1 = mild; 2 = moderate; 3 = severe) (Righini et al., 2004) .
Surface measurements in the midbrain and pons
Measurements were performed using the native 3D T 1 -weighted images. Measurements were obtained for the surface of the midbrain and the pons in a single sagittal slice passing at the level of the mid-sagittal plane. The width of the middle and superior cerebellar peduncles were measured as described previously (Quattrone et al., 2008) . Measurements were normalized for the intracranial volume. Intracranial volume was estimated by measuring the inner intracranial surface of the skull on the midsagittal T 1 -weighted image, which is a good estimate of the total intracranial volume (Fergusson et al., 2005) . Normalized surfaces and widths were calculated by dividing each measurement by the intracranial surface Â 10 À4 .
Two other indices were also calculated. The antero-posterior midbrain diameter (Righini et al., 2004) and the magnetic resonance parkinsonism index (MRPI; Quattrone et al., 2008) . The MRPI combined measurements of the surfaces of the midbrain and the width of the middle cerebellar peduncle and superior cerebellar peduncle [(pons/ midbrain) Â (middle cerebellar peduncle/superior cerebellar peduncle)].
Magnetic resonance spectroscopy in the lenticular nucleus
The resonances of N-acetylaspartate (NAA), creatinine and choline were integrated as previously described (Haïk et al., 2008) and the NAA/creatinine, choline/creatinine and NAA/choline ratios were calculated. Seven patients with Guadeloupean parkinsonism, nine with progressive supranuclear palsy and eight controls were analysed; the other spectra were discarded because of motion artefacts.
Statistical analysis Voxel-based morphometry and voxel-based diffusion tensor imaging analyses
Groups were compared using analysis of covariance (ANCOVA). Age was incorporated in the design matrix to remove regional differences between groups due to age. All tests on fractional anisotropy were performed using an absolute threshold of fractional anisotropy 40.2, such that voxels with fractional anisotropy values 50.2 were not considered for analysis. This threshold restricted the analysis to white matter voxels only. We used a threshold of P50.05 and t43.8 with false discovery rate whole brain correction.
Regions of interest analysis
Analyses were conducted using statistical software (SPSS Inc., version 11.0, Chicago, IL, USA). Dependent variables were brainstem surfaces normalized by intracranial surface and MRS ratios in the different regions. All values are expressed as median and ranges. Statistical comparisons were performed using non-parametric procedures: the Kruskal-Wallis test and post-hoc Mann-Whitney U-test. Significance level was set at P50.05. A step-wise correction for multiple comparisons was applied.
Results
Clinical features
Guadeloupean parkinsonism presented with parkinsonism, axial rigidity and postural instability with severe cognitive impairment (Table 1) . Vertical saccade velocity was reduced in six patients. Myoclonus was arrhythmic and of small amplitude, observed at rest and during action and was detected in seven patients. Vivid, visual hallucinations (animals, faces, deceased relatives) were present in five patients and seven had rapid eye movement sleep disorder behaviour. The patients with progressive supranuclear palsy corresponded to the Richardson's syndrome subtype: all of them presented with parkinsonism and axial rigidity, postural instability and fall. Eye movement was impaired with slow and hypometric saccades in upward and downward directions (Table 1) .
Visual assessment
Results of visual assessment of T 1 -and T 2 -weighted images are presented in Table 2 and Fig. 1 . The hummingbird sign was observed in eight patients with progressive supranuclear palsy, only one patient with Guadeloupean parkinsonism and none of the control subjects. Ten patients with progressive supranuclear palsy presented an abnormal flat or concave superior profile of the midbrain, as compared with four patients with Guadeloupean parkinsonism; whereas only one control subject presented a flat superior profile (P = 0.04, chi square, Yates corrected). The midbrain axial interpeduncular index was significantly more severe in patients with progressive supranuclear palsy and Guadeloupean parkinsonism than in control subjects (P = 0.006, chi square, Yates corrected) and did not differ between the two groups of patients. There were no significant differences in the proportion of midbrain and putamen signal abnormalities between the three groups (chi square, Yates correction).
Voxel-based morphometry analysis Grey matter volumes
Results are given in Table 3 and Fig. 2 . In patients with Guadeloupean parkinsonism compared with control subjects, there were lower grey matter volumes in the bilateral orbitofrontal cortex, inferior and medial occipital cortices, inferior and medial temporal lobes, insula, posteromedial thalamus and cerebellum and the left superior temporal gyrus.
In patients with progressive supranuclear palsy compared with control subjects, there were lower grey matter volumes found in the medial thalamus and the anterodorsal midbrain/hypothalamic area.
In patients with Guadeloupean parkinsonism compared with those with progressive supranuclear palsy, there were lower grey Figure 1 MRI characteristics in one control subject (upper row), one patient with Guadeloupean parkinsonism (Gd-PSP; middle row) and one patient with progressive supranuclear palsy (PSP; lower row). Images are sagittal and axial 3D T 1 -weighted images (left columns), and axial fluid-attenuated inversion recovery images passing at the level of the midbrain and the putamen (right columns). The patient with Guadeloupean parkinsonism had a flat superior profile of the midbrain (arrow) and mild midbrain atrophy on the T 1 -weighted images with enlargement of the interpeduncular cistern (arrowhead). On fluid-attenuated inversion recovery images, there was a hypersignal in the midbrain (arrowhead) and the posterolateral putamen had normal signal intensity (arrowheads). The patients with progressive supranuclear palsy had a typical hummingbird sign with a concave superior profile of the midbrain (arrow) and mild midbrain atrophy on T 1 -weighted images (arrowhead). On fluid-attenuated inversion recovery images, there was a hypersignal in the midbrain (arrowhead), and the posterolateral putamen presented a signal equal to that in the globus pallidus (arrowheads). The control subject also had a hypersignal in the midbrain on fluid-attenuated inversion recovery images (arrowhead). matter volumes in the orbitomedial frontal cortex and the fusiform gyri bilaterally, in the superior temporal gyrus in the left hemisphere and in the cuneus/calcarine area, lingual gyrus of the occipital lobes in the right hemisphere and the right cerebellum. There was no area of decreased grey matter volume in controls compared with patients or in progressive supranuclear palsy compared with Guadeloupean parkinsonism.
White matter volumes
Results are presented in Table 4 and Fig. 3 . In patients with Guadeloupean parkinsonism compared with control subjects, there were decreased white matter volumes in the splenium of the corpus callosum, the area of the left lenticular nucleus and bilaterally in the temporal and occipital lobes, the cerebral peduncles, the inferior cerebellar peduncles and the cerebellum.
In patients with progressive supranuclear palsy compared with control subjects, there were decreased white matter volumes in the posterior part of the body of the corpus callosum, in the white matter lining the caudate nucleus, the genu of the internal capsule, the external capsule/insular area, the basal forebrain/inferior globus pallidus/subthalamic area, the midbrain, the pons and the superior cerebellar peduncles bilaterally, the premotor area in the right hemisphere and the precentral area, the isthmus of the temporal lobe, the inferior cerebellar peduncle and the cerebellum in the left hemisphere.
In patients with progressive supranuclear palsy, there were decreased white matter volumes when compared with Guadeloupean parkinsonism in the body of the corpus callosum and the right external capsule. There was also a cluster in the upper midbrain/medial thalamic area that failed to reach significance after false discovery rate correction.
Voxel-based diffusion tensor imaging
DTI results are presented in Table 5 and Fig. 4 for apparent diffusion coefficient measurements and Table 6 
Patients with Guadeloupean parkinsonism compared with control subjects
Patients with Guadeloupean parkinsonism exhibited an increased apparent diffusion coefficient in several white matter regions including the central area, ventrolateral prefrontal, medial prefrontal and orbitofrontal regions and the operculum bilaterally in the frontal lobes, bilateral cingulate regions, bilateral parietal, temporal, occipital and insular regions, the left medial premotor and medial temporal lobe, the right dorsolateral prefrontal area and cerebellum, the splenium of the corpus callosum, the putamen, the ventral pallidum/basal forebrain area and the thalamus bilaterally. In Guadeloupean parkinsonism, there was decreased fractional anisotropy in the white matter of the corpus callosum, the occipital white matter in the left hemisphere and the right central white matter. There was no area of increased fractional anisotropy in patients with Guadeloupean parkinsonism. Activations were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected.
Patients with progressive supranuclear palsy compared with control subjects
Patients with progressive supranuclear palsy exhibited an increased apparent diffusion coefficient bilaterally in the frontal white matter, including the lateral and medial premotor, dorsolateral and medial prefrontal areas and the frontal poles bilaterally, the corpus callosum, the left central area, the temporal white matter in the region of the isthmus of the left temporal lobe, the right temporal pole, in the hippocampus and parahippocampal gyrus, the occipital white matter, the insula, the operculum, the anterior and posterior cingulate regions, the lenticular nuclei, ventrolateral and dorsomedial regions of the thalamus, the midbrain and the superior cerebellar peduncles bilaterally, as well as the right cerebellum.
Patients with progressive supranuclear palsy had lower fractional anisotropy in the white matter of the corpus callosum, the left inferior parietal and temporal white matter, the right prefrontal white matter and bilaterally in the pre-and postcentral, lateral compared with controls (C) (upper row), progressive supranuclear palsy (PSP) compared with controls (middle row) and progressive supranuclear palsy compared with Guadeloupean parkinsonism (lower row). Statistical parametric maps are presented on the averaged normalized T 1 -weighted image of all control subjects. Voxels were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected. Left is right. Scale bar indicates t-score.
and medial premotor and occipital white matter, the thalamus, the decussation of the superior cerebellar peduncle, the midbrain and cerebellum. There was no area of increased fractional anisotropy in progressive supranuclear palsy.
Patients with progressive supranuclear palsy compared with those with Guadeloupean parkinsonism There was no difference in apparent diffusion coefficient between the two groups of patients. There was only a cluster of lower fractional anisotropy in patients with Guadeloupean parkinsonism compared with patients with progressive supranuclear palsy in the left occipital white matter in the area of the optic radiations that failed to reach significance after false discovery rate correction (results not shown). Compared with patients with Guadeloupean parkinsonism, those with progressive supranuclear palsy had lower fractional anisotropy in the corpus callosum, the left lateral occipital white matter and cerebellum, the right anterior cingulum, internal and external capsule, in bilateral central, precentral and temporal white matter and the white matter lining the caudate nuclei, and at the level of the decussation of the superior cerebellar peduncles.
Region of interest measurements
Results are presented in Table 7 and Fig. 6 . The Kruskal-Wallis test was first conducted to determine whether there was a betweengroups difference in brainstem surfaces and ratios. The KruskalWallis test was significant in the midbrain (P50.001), the pons (P = 0.046), the superior cerebellar peduncle (P = 0.001) and the middle cerebellar peduncle (P = 0.018) and for the midbrain/pons ratio (P = 0.001). Then, pairwise comparisons using the MannWhitney test were conducted to determine whether surfaces differed between groups. Compared with controls, there was a significant reduction of the midsagittal surface of the midbrain (P50.001), the pons (P = 0.022) and the midbrain/pons ratio (P = 0.001) in progressive supranuclear palsy, whereas only the midbrain/pons was affected in Guadeloupean parkinsonism (midbrain P = 0.085, pons, P = 0.69, midbrain/pons, P = 0.047). There was also a significant reduction of the midsagittal surface of the midbrain and the midbrain/pons ratio (P = 0.002 and P = 0.01, respectively) but not the pons (P = 0.065) in progressive supranuclear palsy as compared with Guadeloupean parkinsonism. There was a reduction in the widths of the superior cerebellar peduncle and middle cerebellar peduncle in both progressive supranuclear palsy (P = 0.001 and P = 0.01, respectively) and Guadeloupean parkinsonism (P = 0.001 and P = 0.024, respectively) compared with the controls. The reduction in superior cerebellar peduncle widths was slightly greater in progressive supranuclear palsy than in Guadeloupean parkinsonism, but this difference was not significant.
The Kruskal-Wallis test was significant for the AP midbrain diameter (P = 0.001) and the MRPI (P50.001). Follow-up Mann-Whitney tests showed a reduction of the AP midbrain diameter in patients with progressive supranuclear palsy compared with both controls and patients with Guadeloupean parkinsonism (P50.001 and P = 0.001, respectively) and an increase of the MRPI in both progressive supranuclear palsy and Guadeloupean parkinsonism patients compared with controls (P50.001 and P = 0.006, respectively), as well as a greater increase of the MRPI in patients with progressive supranuclear palsy than in those with Guadeloupean parkinsonism (P = 0.003). 
Magnetic resonance spectroscopy in the lenticular nucleus
The Kruskal-Wallis test was first conducted to determine whether there was a between-group difference in metabolite ratios. The Kruskal-Wallis test was significant for NAA/creatinine ratios only (P = 0.01). Follow-up Mann-Whitney tests showed that NAA/creatinine ratios were lower in progressive supranuclear palsy (NAA/ creatinine = 1.26, min/max = 1.02/1.76, P = 0.011) compared with controls (NAA/creatinine = 1.72, min/max = 1.25/2.03). The decrease was less pronounced in Guadeloupean parkinsonism (NAA/creatinine = 1.55, min/max = 1.37/1.62, P = 0.014). There was no significant difference between Guadeloupean parkinsonism and progressive supranuclear palsy (Fig. 7) .
Discussion
Using multimodal MRI, we observed that the lesion pattern in Guadeloupean parkinsonism differed from progressive supranuclear palsy. In Guadeloupean parkinsonism, structural changes predominated in the temporal lobes, limbic areas (medial temporal and orbitofrontal cortex), the splenium of the corpus callosum and the cerebellum. In patients with progressive supranuclear palsy, structural changes predominated in the midbrain, the basal ganglia, the medial thalamus and the premotor area. This pattern of predominant cortical temporolimbic abnormalities in Guadeloupean parkinsonism and midbrain, basal ganglia and frontocentral white matter lesions in progressive supranuclear palsy helps to differentiate between the two groups and probably accounts for the differences in cardinal signs associated with each disease. In Guadeloupean parkinsonism, grey matter atrophy was widespread in the cortex, affecting large cortical areas including inferior and medial areas of the temporal lobes, the occipital lobes, the orbitomedial and ventrolateral frontal cortices, the insula and the cerebellum, whereas the midbrain was relatively spared. Structural white matter abnormalities were observed in the occipital and temporal white matter, the splenium of the corpus callosum and the cerebellum. Although there was no significant difference in the Figure 3 Statistical parametric maps demonstrating the decrease in white matter in Guadeloupean parkinsonism (Gd-PSP) compared with controls (C) (upper row), progressive supranuclear palsy (PSP) compared with controls (middle row) and Guadeloupean parkinsonism compared with progressive supranuclear palsy (lower row). Statistical parametric maps are presented on the averaged normalized T 1 -weighted image of all control subjects. Voxels were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected. Left is right. Scale bar indicates t-score. midbrain and the pons, the ratio was decreased and the MRPI was increased, suggesting that midbrain atrophy was indeed present but to a lesser degree. Similarly, the superior cerebellar peduncles presented reduced widths, although no changes were detected using voxel-based comparisons in contrast to patients with progressive supranuclear palsy.
DTI provides an estimate of the microstructural integrity of the brain parenchyma through quantitative measures such as apparent diffusion coefficient and fractional anisotropy, which respectively assess the magnitude and the orientation of diffusion (Le Bihan et al., 2001) In Guadeloupean parkinsonism, there were widespread diffusion abnormalities in cortical and subcortical areas. Diffusion changes in the frontal white matter predominating in the inferior and medial frontal regions, the medial and anterior Activations were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected.
temporal and occipital white matter, the splenium of the corpus callosum, the cingulum, the basal ganglia (including the posterior putamen), the thalamus and the cerebellum. This contrasted with patients with progressive supranuclear palsy who had fewer inferior frontal and medial temporal changes as well as midbrain and superior cerebellar peduncle apparent diffusion coefficient increase. MRS analysis showed a reduction in the NAA/creatinine ratio in the lenticular nucleus of patients with Guadeloupean parkinsonism, although less marked than in those with progressive supranuclear palsy. NAA is believed to be a marker for neuronal number and health. Therefore, the NAA/creatinine ratio indicated neuronal loss or neuronal dysfunction in the lenticular nucleus of patients with progressive supranuclear palsy and a less structural involvement in those with Guadeloupean parkinsonism.
To date, Guadeloupean parkinsonism patients have been explored with only visual evaluation of brain morphology using conventional MRI in 31 patients, different from those included in the present study, by two independent neuroradiologists . Visual observation was mostly in agreement with our results, and we report additional occipital involvement and more precise localization of brain atrophy. Widespread supratentorial atrophy and enlargement of the ventricles, particularly the third ventricle, were observed . Cortical atrophy was most pronounced in the frontal and temporal lobes. Cerebellar atrophy was observed in 61% of the patients . Upper mesencephalic atrophy was mild in 36% and more severe in 32% . VBM and DTI results provided a more comprehensive mapping of the damaged brainstem areas in Guadeloupean parkinsonism. The observation of mild brainstem atrophy was confirmed by the present results showing only mild involvement of the midbrain in patients with Guadeloupean parkinsonism. We did not observe grey or white matter changes using VBM in the midbrain but a mild reduction using region of interest measurements, which showed a reduction of the midbrain/pons ratio and an increase of the MRPI but no reduction of the midbrain surface itself, and no diffusion changes. The lesser involvement of the midbrain in Guadeloupean parkinsonism than in progressive supranuclear palsy reflects differential involvement of grey matter and white matter tracts and probably subtle clinical differences.
In progressive supranuclear palsy, our results confirm and expand the results from the literature. Visual evaluation of images showed the usual signs of progressive supranuclear palsy atrophy, including the hummingbird sign with a concave superior profile of the midbrain and midbrain atrophy on axial slices (Kato et al., 2003; Righini et al., 2004) . We also confirm that signal changes were not useful markers to differentiate progressive supranuclear palsy from controls (Righini et al., 2004) compared with controls (C) (upper row) and progressive supranuclear palsy (PSP) compared with controls (lower row). Statistical parametric maps are presented on the average normalized b0 image of all control subjects. Voxels were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected. Left is right. Scale bar indicates t-score. Paviour et al., 2006; Quattrone et al., 2008) . They also confirm that the MRPI, an index obtained by calculating pons/midbrain Â middle cerebellar peduncle/superior cerebellar peduncle ratio, showed better performances than the midbrain/pons ratio for distinguishing progressive supranuclear palsy from controls, and also from Guadeloupean parkinsonism (Quattrone et al., 2008) . Using VBM, grey and white matter reductions have been constantly reported in the midbrain and more variably in the basal ganglia, the frontal cortex, the insula and the thalamus in agreement with our results (Brenneis et al., 2004; Cordato et al., 2005; Boxer et al., 2006; Padovani et al., 2006) . Brainstem atrophy with involvement of the cortex and the underlying white matter was consistent with clinical and neuropathological features, as recently shown in a VBM study of subsequently autopsy-proven progressive supranuclear palsy cases (Josephs et al., 2008) . Using diffusion imaging and region of interest measurements, increased diffusivity has been reported in the basal ganglia (Seppi et al., 2003; Rizzo et al., 2008) , the midbrain (Blain et al., 2006) , the superior cerebellar peduncle and the precentral white matter (Ohshita et al., 2000) . Using voxel-based diffusion techniques, an increased apparent diffusion coefficient has also been reported in the white matter of patients with progressive supranuclear palsy (Padovani et al., 2006) . Here, we show a predominant involvement of the midbrain, the basal ganglia and the frontocentral white matter. In addition, the reduced NAA/creatinine ratio found in the lenticular nucleus in progressive supranuclear palsy was in accordance with previous report (Davie et al., 1997; Federico et al., 1997) .
In this study, combination of different techniques of structural brain imaging shed a light on the relationships between abnormalities observed in distinctive brain areas and the cardinal clinical and electrophysiological features of the two groups of patients. Patients with Guadeloupean parkinsonism reported in the present study were similar to those previously described and were representative of the Guadeloupean parkinsonism population. Dementia and hallucinations were predominant features of Guadeloupean parkinsonism compared with progressive supranuclear palsy. In our previous series, dementia affected 92% of patients with Guadeloupean parkinsonism as compared with the 52-74% of those with classical progressive supranuclear palsy . Hallucinations were observed in 59% of the patients and were mainly visual and unrelated to medication . The severe cortical and subcortical lesions in the temporal and occipital lobes, including white matter volume reduction and fractional anisotropy decrease along the optic radiations, may provide an explanation to the cognitive decline and hallucinations observed in Guadeloupean parkinsonism. Temporal (Harding et al., 2002) and occipital cortical abnormalities (O'Brien et al., 2008) have been incriminated in the occurrence of visual hallucinations in Lewy body disease. In the occipital lobe of these patients, a medial occipital cortex/cuneus area, overlapping with the region that showed reduced grey matter density and increased apparent diffusion coefficient in patients with Guadeloupean parkinsonism, had increased nicotinic acetylcholine receptor labelling in patients presenting with a recent history of visual hallucinations (O'Brien et al., 2008) . In autopsy patients with dementia with Lewy bodies, visual hallucinations were associated with high Activations were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected.
densities of lewy bodies in the amygdala, parahippocampus and inferior temporal cortices, both regions being more affected in patients with Guadeloupean parkinsonism than in those with progressive supranuclear palsy (Harding et al., 2002) .
The pattern of oculomotor abnormalities differed in Guadeloupean parkinsonism compared with classical progressive supranuclear palsy. In patients with Guadeloupean parkinsonism, vertical and horizontal saccade slowing and square wave jerks that Figure 5 Statistical parametric maps demonstrating a fractional anisotropy decrease in Guadeloupean parkinsonism (Gd-PSP) compared with controls (C) (upper row), progressive supranuclear palsy (PSP) compared with controls (middle row) and Guadeloupean parkinsonism compared with progressive supranuclear palsy (lower row). Statistical parametric maps are presented on the average normalized b0 image of all control subjects. Voxels were considered significant at P50.05 and t43.8, false discovery rate whole brain corrected. Left is right. Scale bar indicates t-score. reflect brainstem-cerebellar dysfunctions were minimal, whereas cortical dysfunctions (increased saccade latencies and high anti-saccades error rates) were important (Apartis et al., 2008) . In this article, the authors suggested that cortical oculomotor areas, especially the prefrontal cortex, were impaired in patients with Guadeloupean parkinsonism, whereas brainstem-cerebellar structures were relatively spared. In the present study, the importance of cortical lesions over the minimal midbrain involvement gives a strong anatomical correlate to these clinical and electrophysiological oculomotor findings. In contrast, the supranuclear palsy with vertical saccade impairment observed in progressive supranuclear palsy is related to upper brainstem circuit dysfunctions including the superior collicullus, midbrain reticular formation and the rostral interstitial nucleus of the medial longitudinal fasciculus (Pierrot-Deseilligny et al., 1989) in line with the severe abnormalities observed predominantly in the midbrain of the patients with progressive supranuclear palsy.
VBM changes observed in progressive supranuclear palsy have been confirmed neuropathologically (Josephs et al., 2008) . Brainstem structural abnormalities detected using VBM were Figure 6 Boxplots of the surfaces of the midbrain (1) and pons (2), the midbrain/pons ratio and the MRPI in the three groups of subjects showing median, interquartile range, minimum and maximum. (3) The inner surface of the skull was used for normalization. The midbrain/ pons ratio was significantly decreased and the MRPI was increased in the two groups of patients and changes were more severe in progressive supranuclear palsy (PSP) than Guadeloupean parkinsonism (Gd-PSP). Significance levels are indicated using symbols: # P50.05 and ## P50.01 for Guadeloupean parkinsonism versus controls, *P50.05, **P 0.001 for progressive supranuclear palsy versus controls, § § P 0.01 for progressive supranuclear palsy versus Guadeloupean parkinsonism. Figure 7 Boxplots of the NAA/creatinine (Cr) ratio in controls, progressive supranuclear palsy (PSP) and Guadeloupean parkinsonism (Gd-PSP) patients showing median and interquartile range. This ratio was significantly decreased in progressive supranuclear palsy compared with controls and to a lesser extent in Guadeloupean parkinsonism compared with controls, which is denoted by the asterisks. consistent with neuropathological features in subsequently autopsyproven progressive supranuclear palsy cases (Josephs et al., 2008) . Neuropathological examination was undertaken in three autopsied patients with Guadeloupean parkinsonism . Marked frontal, medial temporal and cerebellar pathology was reported in these patients, in line with the present structural and diffusion results . Similarly, lesions in the basal ganglia, basal forebrain/nucleus basalis of Meynert and brainstem were observed neuropathologically . Although we did not have pathological confirmation of the diagnosis, imaging results suggest that structural and diffusion changes in these regions were less severe in Guadeloupean parkinsonism than in progressive supranuclear palsy.
There were several limitations of this work. Only a limited number of patients were examined in the present study. Guadeloupean parkinsonism is a rare disease, and imaging data were difficult to obtain. Imaging patterns obtained in a similar number of patients with progressive supranuclear palsy were consistent with previous results. Individual region of interest measurements confirmed group results. Moreover, the comparison between the two groups of patients clearly showed differences. Together, the results suggest that voxel-based and region of interest methods were able to detect accurately structural and diffusion changes in these patients and highlight the between-group differences. Secondly, the study was performed at 1.5 T, which limits the spatial resolution of acquisition, particularly for MRS. MRS voxel size was large compared with the size of the putamen but within the range of size of previous studies performed at 1.5 T (Davie et al., 1997; Federico et al., 1997) . The MRS voxel was placed at a distance from the CSF, and therefore no, or very limited, contamination by the CSF was expected. Moreover, NAA, creatinine and choline are not present in the CSF. A further study at higher magnetic field may improve the results.
In conclusion, the pattern of structural and diffusion abnormalities is helpful to discriminate Guadeloupean parkinsonism from progressive supranuclear palsy. Midbrain (progressive supranuclear palsy) or medial temporal/orbitofrontal (Guadeloupean parkinsonism) atrophy was a distinctive neuroradiological feature for differential diagnosis.
